US Patent 8518430 Dry mouldable drug formulation

Patent 8518430 was granted and assigned to Novo Nordisk on August, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Novo Nordisk

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

85184300

Date of Patent

August 27, 2013

Patent Application Number

132854700

Date Filed

October 31, 2011

Patent Citations Received

‌

US Patent 12064520 Components with high API loading

‌

US Patent 11712421 Self-actuating articles

‌

US Patent 11771829 Systems and methods for liquid injection

‌

US Patent 12059562 Systems for electrical stimulation

Patent Primary Examiner

‌

Paul V Ward

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8518430 Dry mouldable drug formulation

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API